000 01292 a2200325 4500
005 20250514045328.0
264 0 _c20021108
008 200211s 0 0 eng d
022 _a0732-183X
024 7 _a10.1200/JCO.2002.99.158
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWölfler, Albert
245 0 0 _aQuestionable benefit of melatonin for antioxidant pharmacologic therapy.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cOct 2002
300 _a4127-8; author reply 4128-9 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAnimals
650 0 4 _aAntioxidants
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
650 0 4 _aFree Radical Scavengers
_xpharmacology
650 0 4 _aHumans
650 0 4 _aMelatonin
_xpharmacology
650 0 4 _aNeoplasms
_xdrug therapy
700 1 _aAbuja, Peter M
700 1 _aLinkesch, Werner
700 1 _aSchauenstein, Konrad
700 1 _aLiebmann, Peter M
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 20
_gno. 19
_gp. 4127-8; author reply 4128-9
856 4 0 _uhttps://doi.org/10.1200/JCO.2002.99.158
_zAvailable from publisher's website
999 _c12164287
_d12164287